Pfizer, Inc. · NYSE:PFE
Pfizer — First Fridays Webinar Series: Medical Education Group (MEG) (February 2011)
21 slides from Pfizer's conference presentation, Feb 4, 2011
Slide 1: First Fridays Webinar Series: Medical Education Group (MEG) Patient-Level Data
First Fridays Webinar Series: Medical Education Group (MEG) Patient-Level Data February 4, 2011 Provide Insights into MEG Operations Share Share Up-To-Date Best Practices Information Webinar Series Goals Respond to How Can Outstanding Pfizer Improve Questions Processes? From Providers 1
Slide 2: Agenda: Patient-Level Data
Agenda: Patient-Level Data • Welcome and Review of MEG Operations • Planning is Everything in the Collection of Patient-Level Data – Sean Hayes, y , PsyD,y , Vice President, AXDEV Group, Inc. and Suzanne Murray President & Founder AXDEV Group, Inc. • Q and A • Closing Remarks The Pfizer Grants Porta
Slide 3: Inside the Resource Center: The MEG 2-Step
Inside the Resource Center Archived Webinars Mouse-over goal statements The MEG 2-Step Evaluate Requestor q MEG Single Reconcile Register Submit Review Decide Notification Pay Event / Close Quarterly Review Multi- step Monitor Program 3
Slide 4: Quarterly Review Schedule 2011
Quarterly Review Schedule 2011 Date Decision To Be Signed LOA Start Date of A li ti Application Period P i d Communicated Deadline Program/Activity By Sept 1, 2010 – Oct 15, 2010 Dec 5, 2010 Jan 1, 2011 or later Dec 1, 2010 – Jan 15, 2011 Mar 4, 2011 Minimum of 2 April 1, 2011 or later weeks before
Slide 5: Planning is Everything in the Collection of Patient-Level Data
Planning is Everything in the Collection of Patient-Level Data Presenters: Suzanne Murray Sean Hayes February 4th, 2011 Agenda Obj ti Objectives 5 minutes i t Context for patient-level data 5 minutes Patient-level data in the educational cycle 5 minutes Planning of patient-level data collection 10 m
Slide 6: Objectives and Disclosure
Objectives At the end of this presentation, participants should recognize: 1.The importance of planning for patient-level assessment 2.The value of patient-level data in assessing health care providers’ competence and performance 3.The broad variety of patient-level data sources available 4.Differen
Slide 7: Who we are
Who we are AXDEV Group is an international Performance Improvement organization that specializes in assisting healthcare organizations and stakeholders improve professional competencies, interdisciplinary team practices, organizational functioning, and clinical practice efficiency. efficiency Copyri
Slide 8: ACCME Criteria for Evaluation of CME
ACCME Criteria for Evaluation of CME Essential Area 3: Evaluation and Improvement • Element 2.4: Evaluate the effectiveness of its CME activities in meeting identified educational needs. • Element 2.5: Evaluate the effectiveness of its overall CME program and make improvements to the program. Crit
Slide 9: Patient-Level Data in CME
Agenda Obj ti Objectives Context for patient-level data Patient-level data in the educational cycle Planning of patient-level data collection • Linking the impact to the education • What is done and what could be done Potential obstacles for patient-level data Q&A Copyright © 2011 AXDEV Group Inc. 1
Slide 10: Patient-Level Data in the Educational Cycle
Patient-Level Data in the Educational Cycle Offer critical source of information regarding NEEDS ASSESSMENT gaps and barriers of health care providers • Triangulation and cross-validation Educational BEHAVIOURAL • Identify EVALUATION Design OBJECTIVES unperceived Process needs Program impact on pati
Slide 11: Patient-Level Data in Needs Assessment
Patient-Level Data in Needs Assessment Presented at Alliance 2008 Copyright © 2011 AXDEV Group Inc. 21 Patient-Level Data in Evaluation Don Moore, Vanderbilt University. Planning for and Assessing the Impact of Learning Activities. First Fridays Webinar Series: Medical Education Group (MEG), August
Slide 12: Patient-Level Data in Evaluation
Patient-Level Data in Evaluation Patients are a valuable source of data regarding participants’ competence and performance Don Moore, Vanderbilt University. Planning for and Assessing the Impact of Learning Activities. First Fridays Webinar Series: Medical Education Group (MEG), August 6th, 2010 Age
Slide 13: Linking Impact to Education
Linking Impact to Education CME Impact on patient outcomes ↑ clinical endpoints: e.g., A1c, BP, CD4 count Copyright © 2011 AXDEV Group Inc. 25 Linking Impact to Education CME Impact on Impact on program patient participants outcomes ↑ clinical endpoints: ↑ Knowledge, ↑ Skill, e.g., A1C, blood ↑ Comp
Slide 14: Linking Impact to Education; What is Generally Done
Linking Impact to Education CME Impact on Performance Impact on program patient participants outcomes ↑ Patient-provider ↑ Competence ↑ Adherence relation Copyright © 2011 AXDEV Group Inc. 27 What is Generally Done Satisfaction questionnaires “Is a more satisfied patient a validation of Self-ass
Slide 15: What Could Be Done; Patient-Level Data Collection
What Could Be Done Patient Journey (experience) Mapping • Satisfaction S ti f ti questionnaires ti i • Self-assessments • Surveys Quantitative • Interviews X Combinations • Focus groups Qualitative • Observations • Diaries • Performance tests • Chart audits • Patient data registries Copyright © 20
Slide 16: Patient-Level Data Collection: Essential Questions
Patient-Level Data Collection Essential questions • Why do I need patient data? • How will it demonstrate the impact of the program? • What data collection method best fits? • Do I need protected health information? • Is the data I will be collecting individually identifiable? • Do I need the patien
Slide 17: Privacy (HIPAA)
Privacy (HIPPA) HIPAA Privacy Rule defines protected health information or PHI as individuallyy identifiable health information that is transmitted or maintained in any form or medium (electronic, oral, or paper) by a covered entity or its business associates, excluding certain educational and emp
Slide 18: Privacy (HIPAA); Confidentiality & Anonymity
Privacy (HIPPA) 1. Names 10. Account numbers 2. All geographic subdivisions smaller 11. Certificate/license numbers th a state, than t t exceptt under d certain t i 12. Vehicle identifiers, f serial numbers, condition for the initial three digits of a license plate numbers ZIP Code 13. Device identi
Slide 19: Key Messages
Key Messages • Plan – Plan – Plan • Identify when you need patient level data • Identify when you do not • Map out link between program and patient data collected • Select appropriate collection method • Respect of patients’ privacy, confidentiality and anonymity Copyright © 2011 AXDEV Group Inc. 37
Slide 20: Conclusion; Thank you!
Conclusion Patients are a valuable source of data regarding health care providers’ id ’ competence t andd performance f Good planning of the patient-level data collection process will : • Ensure data is collected respecting patients’ privacy, confidentiality and anonymity • Guide you in selectin
Slide 21: Until Next Time…
Until Next Time… • Please join us for our next webinar – Block Grants – Guest Speakers: Bob Addleton, Ed.D. and David Pieper, PhD – Friday, March 4th, 2011 – 11am 11 ET • Next grant window opens March 1, 2011 for activities to occur July 1, 2011 or later • See what providers are doing to move educat
Pfizer — First Fridays Webinar Series: Medical Education Group (MEG) (February 2011) on 6ix